Identification of Potential target genes of butyrate in dimethylhydrazine-induced colorectal cancer in mice

Nutrition and Cancer

Volumn 65, Issue 8, 2013, Pages 1171-1183

  Chen, Hui Min ^a,b,c   Lin, Yan Wei ^a,b,c   Wang, Ji Lin ^a,b,c   Kong, Xuan ^a,b,c   Hong, Jie ^a,b,c   Fang, Jing Yuan ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c School of Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; BUTYRIC ACID; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; VASCULOTROPIN;

ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WNT SIGNALING PATHWAY;

MUS;

1,2-DIMETHYLHYDRAZINE; ANIMALS; BUTYRATES; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; MICE; MICE, INBRED ICR; MICROARRAY ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84888367354     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.828087     Document Type: Article

References (54)

1. Center MM, Jemal A, andWard E: International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 18, 1688-1694, 2009.
2. Xiong F, Wu C, Bi X, Yu D, Huang L, et al. : Risk of genome-wide association study-identified genetic variants for colorectal cancer in a Chinese population. Cancer Epidemiol Biomarkers Prev 19, 1855-1861, 2010.
3. Reedy J, Mitrou PN, Krebs-Smith SM, Wirf̈alt E, Flood A, et al.: Indexbased dietary patterns and risk of colorectal cancer: the NIHAARP Diet and Health Study. Am J Epidemiol 168, 38-48, 2008.
4. Park Y, Hunter DJ, Spiegelman D, Bergkvist L, Berrino F, et al.: Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 294, 2849-2857, 2005.
5. Koushik A, Hunter DJ, Spiegelman D, Beeson WL, van den Brandt PA, et al.: Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst 99, 1471-1483, 2007.
6. Dashwood RH, Myzak MC, and Ho E: Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?. Carcinogenesis 27, 344-349, 2006.
7. Kuefer R, HoferMD, Altug V, Zorn C, Genze F, Kunzi-Rapp K, Hautmann RE, Gschwend JE: Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer. Br JCancer 90, 535-541, 2004.
8. Bhatnagar N, Li X, Chen Y, Zhou X, Garrett SH, et al.: 3,3-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin. Cancer Prev Res 2, 281-289, 2009.
9. Femia AP, and Caderni G: Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products. Planta Med 74, 1602-1607, 2008.
10. Kinjo T, Suzui M, Morioka T, Nabandith V, InamineM, et al.: Distribution of preneoplastic lesions and tumors, and beta-catenin gene mutations in colon carcinomas induced by 1,2-dimethylhydrazine plus dextran sulfate sodium. J Exp Clin Cancer Res 25, 89-95, 2006.
11. Lu R, Wang X, Sun DF, Tian XQ, Zhao SL, et al.: Folic acid and sodium butyrate prevent tumorigenesis in a mouse model of colorectal cancer. Epigenetics 3, 330-335, 2008.
12. Femia AP, Luceri C, Toti S, Giannini A, Dolara P, et al.: Gene expression profile and genomic alterations in colonic tumours induced by 1,2-dimethylhydrazine (DMH) in rats. BMC Cancer 11(10), 194, 2010.
13. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al.: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25, 25-29, 2000.
14. Bonnet A, Lagarrigue S, Liaubet L, Robert-Graníe C, SancristobalM, et al.: Pathway results from the chicken data set using GOTM, Pathway Studio and Ingenuity softwares. BMC Proc 3, S4-S11, 2009.
15. Scanlan MJ,Welt S, Gordon CM, Chen YT, Gure AO, et al.: Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Res 62, 4041-4047, 2002.
16. Isräel M, and Schwartz L: The metabolic advantage of tumor cells. Mol Cancer 10, 70, 2011.
17. Davie JR: Inhibition of histone deacetylase activity by butyrate. J Nutr 133(7, Suppl), 2485S-2493S, 2003.
18. Hodin R: Maintaining gut homeostasis: the butyrate-NF-kappaB connection. Gastroenterology 118, 798-801, 2000.
19. Louis M, Rosato RR, Brault L, Osbild S, Battaglia E, et al.: The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress. Int J Oncol 25, 1701-1711, 2004.
20. Yin L, Laevsky G, and Giardina C: Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J Biol Chem 276, 44641-44646, 2001.
21. Fusco AJ, Huang DB, Miller D, Wang VY, Vu D, and Ghosh G: NFkappaB p52:RelB heterodimer recognizes two classes of kappaB sites with two distinct modes. EMBO Rep 10, 152-159, 2009.
22. Roth SY, Denu JM, and Allis CD: Histone acetyltransferases. Annu Rev Biochem 70, 81-120, 2001.
23. Bitko V, Velazquez A, Yang L, Yang YC, and Barik S: Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin. Virology 232, 369-378, 1997.
24. Hinz M, Lemke P, Anagnostopoulos I, Hacker C, Krappmann D, et al.: Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 196, 605-617, 2002.
25. Zucker S, and Vacirca J: Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 23, 101-117, 2004.
26. Leeman MF, Curran S, and MurrayGI: Newinsights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 201, 528-534, 2003.
27. Bousserouel S, Kauntz H, Gosśe F, Bouhadjar M, Soler L, et al.: Identification of gene expression profiles correlated to tumor progression in a preclinical model of colon carcinogenesis. Int J Oncol 36, 1485-1490, 2010.
28. Brunckhorst MK, Wang H, Lu R, and Yu Q: Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis. Cancer Res 70, 7283-7293, 2010.
29. OlsenMW, Ley CD, Junker N, Hansen AJ, Lund EL, et al.: Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure. Neoplasia 8, 364-372, 2004.
30. Birts CN, Barton CH, andWilton DC: Catalytic and non-catalytic functions of human IIA phospholipase A2. Trends Biochem Sci 35, 28-35, 2010.
31. Fijneman RJ, and Cormier RT: The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine. Front Biosci 13, 4144-4174, 2008.
32. Belinsky GS, Rajan TV, Saria EA, Giardina C, and Rosenberg DW: Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth. Mol Carcinog 46, 106-116, 2007.
33. Seeds MC, Grier BL, Suckling BN, Safta AM, Long DL, et al.: Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome. Am J Med Sci 343, 446-451, 2012.
34. Fijneman RJ, Bade LK, Peham JR, van de Wiel MA, van Hinsbergh VW, et al.: Pla2g2a attenuates colon tumorigenesis in azoxymethane-treated C57BL/6 mice; expression studies reveal Pla2g2a target genes and pathways. Cell Oncol 31, 345-356, 2009.
35. Xing XF, Li H, Zhong XY, Zhang LH,Wang XH, et al.: Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer. Histopathology 59, 198-206, 2011.
36. Negrutskii BS, and El'skaya AV: Eukaryotic translation elongation factor 1 alpha: structure, expression, functions, and possible role in aminoacyltRNA channeling. Prog Nucleic Acid Res Mol Biol 60, 47-78, 1998.
37. Kim J, Namkung W, Yoon JS, JoMJ, Lee SH, et al.: The role of translation elongation factor eEF1A in intracellular alkalinization-induced tumor cell growth. Lab Invest 89, 867-874, 2009.
38. Rhee DJ, Haddadin RI, Kang MH, and Oh DJ: Matricellular proteins in the trabecular meshwork. Exp Eye Res 88, 694-703, 2009.
39. Maillard C, Malaval L, and Delmas PD: Immunological screening of SPARC/Osteonectin in nonmineralized tissues. Bone 13, 257-264, 1992.
40. Fenouille N, Robert G, Tichet M, Puissant A, Dufies M, et al.: The p53/p21(Cip1/Waf1) pathway mediates the effects of SPARC on melanoma cell cycle progression. Pigment Cell Melanoma Res 24, 219-232, 2011.
41. Jeung HC, Rha SY, Im CK, Shin SJ, Ahn JB, et al.: A randomized phase 2 study of docetaxel and S-1 versus cocetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy. Cancer 117, 2050-2057, 2011.
42. Girirajan S, Hauck PM, Williams S, Vlangos CN, Szomju BB, et al.: Tom1l2 hypomorphic mice exhibit increased incidence of infections and tumors and abnormal immunologic response. Mamm Genome 19, 246-262, 2008.
43. Greaves J, and Chamberlain LH: Differential palmitoylation regulates intracellular patterning of SNAP25. J Cell Sci 124, 1351-1360, 2011.
44. Hu H, Marton TF, and Goodman CS: Plexin B mediates axon guidance in Drosophila by simultaneously inhibiting active Rac and enhancing RhoA signaling. Neuron 32, 39-51, 2001.
45. Nakamura F, Kalb RG, and Strittmatter SM:Molecular basis of semaphorinmediated axon guidance. J Neurobiol 44, 219-229, 2000.
46. Tessier-Lavigne M, and Goodman S: The molecular biology of axon guidance. Science 274, 1123-1133, 1996.
47. Winberg ML, Noordermeer JN, Tamagnone L, Comoglio PM, Spriggs MK, et al.: Plexin A is a neuronal semaphoring receptor that control axon guidance. Cell 95, 903-916, 1998.
48. Machado RA, Constantino LD, Tomasi CD, Rojas HA, Vuolo FS, et al.: Sodium butyrate decreases the activation of NF-?B reducing inflammation and oxidative damage in the kidney of rats subjected to contrastinduced nephropathy. Nephrol Dial Transplant 2012 Jan 23. (Epub ahead of print.)
49. Sun B, Liu R, Xiao ZD, and Zhu X: c-MET Protects Breast Cancer Cells from Apoptosis Induced by Sodium Butyrate. PLoS One 7, e30143, 2012. Epub
50. Jiang W, Guo Q, Wu J, Guo B, Wang Y, et al.: Dual effects of sodium butyrate on hepatocellular carcinoma cells. Mol Biol Rep 2012 Jan 7. (Epub ahead of print.)
51. Shin H, Lee YS, and Lee YC: Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells. Oncol Rep 27, 1111-1115, 2012.
52. Silva PF, Garcia VA, Dornelles Ada S, Silva VK, Maurmann N, et al.: Memory impairment induced by brain iron overload is accompanied by reduced H3K9 acetylation and ameliorated by sodium butyrate. Neuroscience 200, 42-49, 2012.
53. Tilstone C: DNA microarrays: Vital statistics. Nature 424, 610-612, 2003.
54. Lee ML, Kuo FC, Whitmore GA, and Sklar J: Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proc Natl Acad Sci USA 97, 9834-9839, 2000.